Chesapeake Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-9
Closed -$9 582
2024
Q4
$9 Hold
9
﹤0.01% 519
2024
Q3
$22 Hold
9
﹤0.01% 523
2024
Q2
$402 Hold
9
﹤0.01% 311
2024
Q1
$396 Buy
+9
New +$768 ﹤0.01% 301
2023
Q4
Sell
-2
Closed -$233 418
2023
Q3
$233 Buy
+2
New +$167 ﹤0.01% 413
2023
Q2
Sell
-7
Closed -$1.08K 468
2023
Q1
$1.08K Buy
+7
New +$571 ﹤0.01% 380

Other funds holding MDT

Chesapeake Asset Management's MDT Position: Q4 2025 in Review

Chesapeake Asset Management sold out of Medtronic (MDT) in Q4 2025, closing a stake of 100 shares — an estimated $9.52K sold.

Chesapeake Asset Management first reported a position in MDT in Q1 2023 and held it in 11 quarters. The position peaked at $643K in Q3 2023. 2,304 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

  • Chesapeake Asset Management reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
  • Chesapeake Asset Management sold 100 Medtronic shares in Q4 2025, an estimated $9.52K.
  • Chesapeake Asset Management first reported a position in Medtronic in Q1 2023 and held it in 11 quarters.
  • Chesapeake Asset Management's Medtronic position peaked at $643K in Q3 2023.
  • 2,304 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Chesapeake Asset Management's 13F filing for Q4 2025, filed 8 Jan 2026.